Antimicrobial Resistance US 2022
In September 2022, Innovate UK took a team of UK experts representing businesses and academia to the US to improve Innovate UK’s understanding of the research and innovation landscape in AMR in the US. The GEM explored potential collaboration opportunities in three thematic areas: 1.Diagnostics. 2. Therapeutics and vaccines. 3.Environmental surveillance.
Abstract from outcome report:
Antimicrobial resistance (AMR) is one of the biggest threats to global health and food security today. The improvident use of antibiotics in both clinical use and animal husbandry has increased the prevalence of AMR. A systematic study on the global burden of AMR found almost 5 million deaths in 2019 were associated with AMR. This highlights the gravity of the situation and the urgency for international cooperation to mitigate the impact of AMR, which has been termed the “hidden pandemic”.
The complexity of AMR owed to the intricate interrelationship between human and animal health, agriculture and the environment makes it difficult to tackle the problem through a single solution. It requires a holistic view through the One Health lens where all sectors work together in a coordinated approach to deliver solutions to combat AMR. The US has provided significant financial contribution to developing new therapeutics and, with a strong research infrastructure, is well placed to bring innovations to the market.
Watch the recording below from our Dissemination Webinar which took place following the Expert Mission.
About Global Expert Missions
The Global Expert Missions (GEM) programme is funded by Innovate UK and designed to build international collaborations with governments, societies, enterprises, institutions, and people from every corner of the globe. With global challenges requiring international perspectives, the programme aims to support the UK government’s ambition to be the international partner of choice and a global hub for innovation by 2035.